Free Trial

Doximity, Inc. (NASDAQ:DOCS) Shares Purchased by Principal Financial Group Inc.

Doximity logo with Medical background
Remove Ads

Principal Financial Group Inc. increased its stake in Doximity, Inc. (NASDAQ:DOCS - Free Report) by 1.5% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 293,974 shares of the company's stock after purchasing an additional 4,282 shares during the period. Principal Financial Group Inc. owned 0.16% of Doximity worth $15,695,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors also recently bought and sold shares of the company. UMB Bank n.a. boosted its stake in Doximity by 69.1% in the 4th quarter. UMB Bank n.a. now owns 575 shares of the company's stock worth $31,000 after purchasing an additional 235 shares in the last quarter. Farther Finance Advisors LLC boosted its stake in Doximity by 324.2% in the 3rd quarter. Farther Finance Advisors LLC now owns 789 shares of the company's stock worth $34,000 after purchasing an additional 603 shares in the last quarter. Morse Asset Management Inc acquired a new stake in Doximity in the 3rd quarter worth approximately $46,000. Covestor Ltd boosted its stake in Doximity by 441.9% in the 3rd quarter. Covestor Ltd now owns 1,680 shares of the company's stock worth $73,000 after purchasing an additional 1,370 shares in the last quarter. Finally, GAMMA Investing LLC boosted its stake in Doximity by 20.6% in the 4th quarter. GAMMA Investing LLC now owns 1,735 shares of the company's stock worth $93,000 after purchasing an additional 296 shares in the last quarter. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, Director Timothy S. Cabral sold 20,000 shares of the company's stock in a transaction on Monday, February 3rd. The shares were sold at an average price of $57.62, for a total transaction of $1,152,400.00. Following the completion of the sale, the director now owns 6,360 shares of the company's stock, valued at $366,463.20. This represents a 75.87 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 37.40% of the stock is owned by insiders.

Remove Ads

Analyst Ratings Changes

A number of analysts recently commented on DOCS shares. Raymond James reiterated an "outperform" rating and issued a $83.00 target price (up from $65.00) on shares of Doximity in a research note on Friday, February 7th. Stephens started coverage on shares of Doximity in a research note on Friday, December 20th. They set an "equal weight" rating and a $55.00 price objective for the company. Canaccord Genuity Group lifted their price objective on shares of Doximity from $60.00 to $71.00 and gave the company a "hold" rating in a research note on Friday, February 7th. Piper Sandler upgraded shares of Doximity from a "neutral" rating to an "overweight" rating and lifted their price objective for the company from $31.00 to $78.00 in a research note on Friday, February 7th. Finally, The Goldman Sachs Group lifted their price objective on shares of Doximity from $58.00 to $80.00 and gave the company a "neutral" rating in a research note on Monday, February 10th. Eleven equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $64.22.

View Our Latest Report on Doximity

Doximity Price Performance

NASDAQ DOCS traded up $0.99 on Friday, hitting $70.44. The company had a trading volume of 2,942,499 shares, compared to its average volume of 2,419,498. The company has a market capitalization of $13.15 billion, a PE ratio of 70.44, a PEG ratio of 4.10 and a beta of 1.39. The company's fifty day moving average price is $61.91 and its 200-day moving average price is $50.51. Doximity, Inc. has a 12-month low of $22.96 and a 12-month high of $85.21.

Doximity Profile

(Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Read More

Institutional Ownership by Quarter for Doximity (NASDAQ:DOCS)

Should You Invest $1,000 in Doximity Right Now?

Before you consider Doximity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.

While Doximity currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Is There Still Money in AI? How to Invest in the Next Big Wave
AMD at Rock Bottom? Analysts Predict a MAJOR Rebound!
Massive Buybacks: 3 Stocks Insiders Are Buying Up

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads